Closing a heart hole to treat drug-resistant epilepsy
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial tests if closing a small hole in the heart (called a PFO) can reduce seizures in people whose epilepsy isn't controlled by medication. It might offer a new treatment option for those who have both drug-resistant epilepsy and this heart condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have epilepsy that hasn't improved with at least two seizure medicines taken for 6 months or more.
- You have a small hole in your heart (PFO) that lets blood flow the wrong way, seen on a special ultrasound.
- You have had at least one seizure in the past 6 weeks and at least 12 seizures in the last year.
- You are willing to keep your current seizure medicines stable during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether closing a small hole in the heart (called a PFO) can help eliminate migraines. If you have frequent migraines and no other major health issues, this procedure might reduce or stop your headaches.
This trial tests a new device that sews shut a small hole in the heart (called a patent foramen ovale, or PFO). This hole may let tiny clots pass from the body to the brain, causing strokes or mini-strokes. If you have had a stroke or mini-stroke linked to this hole, this procedure might help prevent future events.
This trial studies whether a Cera™ device is safe and effective for closing a patent foramen ovale (PFO), a small hole in the heart. It is for adults whose PFO is linked to certain types of stroke or ongoing clot-related events.
This trial tests a device called the Snowy PFO Closure System, which is meant to close a small hole in the heart (PFO) that can let blood clots pass to the brain and cause strokes or migraines. The device is inserted through a small tube, and the study aims to see if it is safe and works well.
This study tests a new dissolvable device that closes a common heart defect called a patent foramen ovale (PFO), which can cause strokes. The device is designed to prevent future strokes and eventually break down in the body.
This trial tests a new device to close a PFO (a small hole between the upper chambers of the heart) in people who have had a stroke caused by a blood clot. The goal is to prevent future strokes by blocking the hole.
Hear when a new Epilepsy (Treatment Refractory) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.